Gainers
ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies.
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Key Takeways:
Qudian was notified by the New York Stock Exchange that it was in violation of listing rules that require its stock price to stay above $1
The warning was its third one this year, and came after the company said it was scaling down a food business it started just six months ago and ceased its main lending business
Key Takeaways:
Sinolink will buy about 156 million new shares in ZhongAn’s overseas business development unit, ZhongAn International, for about $103 million
The deal comes in a difficult year for ZhongAn, whose own cash holdings are dwindling
By Warren Yang
Key Takeaways:
FinVolution’s revenue growth slowed to about 12% in the second quarter from 16% and 32% in the previous two quarters, while its latest quarterly net profit fell about 6%
360 DigiTech and Lexin posted little or no revenue growth for the quarter, as their profits plunged 37% and 80%, respectively, during the period
FinVolution Group (NYSE:FINV) reported quarterly earnings of $0.06 per share. This is a 82.35 percent decrease over earnings of $0.34 per share from the same period last year. The company reported $398.02 million in
Companies Reporting Before The Bell
• Jaguar Health (NASDAQ:JAGX) is estimated to report quarterly loss at $0.22 per share on revenue of $3.10 million.